Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
作者信息
Meier J
出版信息
Acta Med Scand Suppl. 1977;606:65-70. doi: 10.1111/j.0954-6820.1977.tb18031.x.
Abstract
摘要
相似文献
1
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Acta Med Scand Suppl. 1977;606:65-70. doi: 10.1111/j.0954-6820.1977.tb18031.x.
2
[Comparative pharmacokinetics of beta-blockers].
Nouv Presse Med. 1978 Sep 20;7(31):2685-7.
3
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Pharmazie. 1975 Oct;30(10):625-33.
4
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Drugs. 1974;7(1):39-47. doi: 10.2165/00003495-197407010-00003.
5
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
J Mass Spectrom. 1998 Jul;33(7):607-14. doi: 10.1002/(SICI)1096-9888(199807)33:7<607::AID-JMS672>3.0.CO;2-O.
6
The new beta-adrenergic antagonists.
Can Anaesth Soc J. 1984 Jul;31(4):430-3. doi: 10.1007/BF03015419.
7
Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001.
8
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Am J Med. 1976 Nov;61(5):779-89. doi: 10.1016/0002-9343(76)90159-5.
9
Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
Am Heart J. 1982 Aug;104(2 Pt 2):364-73. doi: 10.1016/0002-8703(82)90127-2.
引用本文的文献
1
A standard approach to compiling clinical pharmacokinetic data.
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
2
Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Eur J Clin Pharmacol. 1989;36(1):5-10. doi: 10.1007/BF00561015.
Zotero 插件